News & Events News Back January 13, 2022 Salarius Pharmaceuticals Expands Oncology Pipeline Through Strategic Acquisition of Targeted Protein Degradation Portfolio from DeuteRx, LLC Contact Tiberend Strategic Advisors, Inc. Johanna Bennett jbennett@tiberend.com Download PDF
